Login to Your Account



Politics render Senate hearing on high drug prices a bit un-HELP-ful

By Mari Serebrov
Regulatory Editor

Wednesday, June 14, 2017

Squandering much of what could have been a good opportunity to better understand the pricing of prescription drugs, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee reverted to political bickering over repeal of the Affordable Care Act (ACA) in the first of a series of three hearings billed as a bipartisan fact-finding into the who, what and why of drug prices.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription